IBEX BIOSCIENCES, LLC

Follow

Organization

CUMBERLAND, MD, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Antibodies and therapeutic uses thereof
- Patent number 12,173,057
- Issue date Dec 24, 2024
- Ibex Biosciences, Inc.
- Michael Joseph Karlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of PCBP1 to treat hyperproliferative disease
- Patent number 11,980,670
- Issue date May 14, 2024
- Ibex Biosciences, Inc.
- Norman Zhennan Lai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES TARGETED TO CD147
- Publication number 20240010723
- Publication date Jan 11, 2024
- Ibex Biosciences, Inc.
- Vidal Felix de la CRUZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF PCBP1 TO GENERATE INDUCED PLURIPOTENT STEM CELLS WHILE INHIB...
- Publication number 20220228126
- Publication date Jul 21, 2022
- Ibex Biosciences, LLC
- Norman Zhennan LAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO FILAMIN-A AND THERAPEUTIC USES THEREOF
- Publication number 20220025025
- Publication date Jan 27, 2022
- Ibex Biosciences, LLC
- Michael Joseph KARLIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF PCBP1 TO TREAT HYPERPROLIFERATIVE DISEASE
- Publication number 20210113714
- Publication date Apr 22, 2021
- Ibex Biosciences, LLC
- Norman Zhennan LAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks